CPDA Conference 2025

Laura M. Bohn, Agnes Acevedo-Canabal, Nicole Kennedy, Thomas Bannister, Edward L Stahl.
Yan Zhang
Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University
Andrew S. Huhn Psychiatry and Behavioral Sciences – Behavioral Biology Research Unit, Johns Hopkins University
Yingpeng Liu, Lipin Ji, Fei Tong, Markos Orestis Georgiadis, Spyros P. Nikas, Alexandros Makriyannis.
Center for Drug Discovery, Northeastern University
Vsevolod “Seva” Katritch USC Michelson Center for Convergent Bioscience, Department of Quantitative and Computational Biology, Department of Chemistry, University of Southern California
Daniel Rosenbaum
Department of Molecular Physics, UT Southwestern Medical Center
Lawrence M. Carey1,2, Zhili Xu2, Gabriela Rajic2, Alexandros Makriyannis3, Julian Romero4, Cecilia Hillard5, Ken Mackie1,2,6 and Andrea G. Hohmann1,2,6*
Hideaki Yano
Bouvé College of Health Sciences, School of Pharmacy, Department of Pharmaceutical Sciences, Center for Drug Discovery, Northeastern University
Madelyn H. Ray, BaDoi Phan, Marianne L. Seney, Jill R. Glausier, Allison Tipton, Shelley J. Russek, Andreas Pfenning, David A. Lewis, and Ryan W. Logan
Bryan Roth
Department of Pharmacology, University of North Carolina
Randal A. Serafinia*, Justin J. Frereb,c*, Jeffrey Zimeringa,d, Kerri D. Prycea, Ilinca M. Giosan, Ilona Golynkerc, Maryline Panisc, Anne Ruiza, Benjamin tenOeverc°, Venetia Zacharioua,e°
S. Stevens Negus
Department of Pharmacology and Toxicology, Virginia Commonwealth University
Lipin Ji1, Anna W. Sromek2, Thanh Ho2, Kiran Vemuri2, Shakiru Alapafuja1, Alexander Zvonok1, Alexandros Makriyannis2*

1MAKScientific 2Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University
Kimberly N. Karin1*, Erica N. Golden1, Raphael Mechoulam2, Linda Parker3, M. Imad Damaj1, Aron H. Lichtman1, and Joel E. Schlosburg1

1Dept of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA 2Institute of Drug Research, Medical Faculty, Hebrew University of Jerusalem, Jerusalem, Israel 3Dept of Psychology and Collaborative Neuroscience Program, University of Guelph, Guelph,2ON, N1G 2W1, Canada
Lipin Ji1, Anna W. Sromek2, Thanh Ho2, Kiran Vemuri2, Shakiru Alapafuja1, Alexander Zvonok1, Alexandros Makriyannis2*

1MAKScientific 2Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University
Yiorgos Skiniotis
Department of Molecular and Cellular Physiology, Department of Structural Biology, Stanford University
Gregory Dudley
C. Eugene Bennett Department of Chemistry, West Virginia University
Christos Iliopoulos-Tsoutsouvas
Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston
Christoph Gorgulla
Harvard Medical School and Department of Physics, Harvard University
Ryan McGlynn1, Meng Cui1, Brittany Brems1, Stephen Kohut3, Alex Yuan1, Raymond G. Booth1,2

1 Department of Pharmaceutical Sciences, Northeastern University, Boston MA, 2 Department of Chemistry, Northeastern University, Boston MA, 3 Department of Physiatry, McLean Hospital, Belmont MA
David E. Nichols
Department Of Pharmacology, Eshelman School of Pharmacy, University of North Carolina
Albert Garcia-Romeu Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine
Balazs R. Varga1, Sarah M. Bernhard1, Amal El Daibani1, Saheem Zaidi2, Kevin Appourchaux1, Samantha Harker1, Alexa Kouvelis1, Shainnel O. Eans3, Vsevolod Katritch2, Jay P. McLaughlin3, Susruta Majumdar1 and Tao Che1

1Center for Clinical Pharmacology, University of Health Sciences & Pharmacy and Washington University School of Medicine, St. Louis, MO, USA 2 Department of Quantitative & Computational Biology and Department of Chemistry, University of Southern California, Los Angeles, CA, USA. 3Department of Pharmacodynamics, University of Florida, Gainesville, FL, USA.
Wilkerson JL1,5, Zuarth Gonzalez JD1,5, Mazpule-Carrigan CC1, Patel RC1, Patel A1, Obeng S1,2, Leon F2, Mottinelli M2, Mukhopadhyay S2, Hiranita T1,5, McCurdy CR2,3,4, and McMahon LR1,5

Departments of Pharmacodynamics1, Medicinal Chemistry2, and Pharmaceutics3, and Translational Drug Development Core, Clinical and Translational Sciences Institute4, College of Pharmacy, University of Florida; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Jerry H. Hodge School of Pharmacy, Texas5
Gisela A. Camacho-Hernandez1; Andrea Casiraghi1,2; Deborah Rudin3; Dino Luethi3,4; Amarachi V. Okorom1; Therese C. Ku1, Daryl A. Guthrie1; Valentina Straniero2; Ermanno Valoti 2; Gerhard J. Schütz, 4; Harald H. Sitte, 3; Amy H. Newman1

1Medicinal Chemistry Section, National Institute on Drug Abuse-IRP, Baltimore, MD USA; 2Department of Pharmaceutical Sciences, University of Milan, Milan, Italy; 3Institute of Pharmacology, Medical University of Vienna, Vienna, Austria; 4Institute of Applied Physics, TU Wien, Vienna, Austria.
Imad Damaj
Department of Pharmacology and Toxicology, Virginia Commonwealth University
Dai Lu, Ph.D.
Rangel College of Pharmacy, Texas A&M University
Neural Consequences of Adolescent Cannabinoid Exposure in Nonhuman Primates
Dr. Stephen Kohut
McLean Hospital
error: Content is protected !!